申请人:SANKYO COMPANY LIMITED
公开号:EP0558749A1
公开(公告)日:1993-09-08
A compound represented by general formula (1), its salt, and antiviral and antitumor drugs containing the same, wherein k is 0 to 20; m is 0 or 1; n is 4 to 29; X represents OH, methyl, sulfhydryl, C₁ to C₄ alkoxy or C₁ to C₆ monoalkylamino; Y and Z represent each O or S; R¹, R² and R³ may be the same or different from each other and each represents H, C₁ to C₆ alkyl, or C₆ to C₁₀ aryl which may have the substitutent(s) of group α; and D and B represent each independently a residue of any of the compounds of group β; provided that m is 0 when k is 0, and a base sequence containing B is complementary to a tumor gene or a virus gene: group α: OH, C₁ to C₆ alkyl, C₁ to C₆ alkoxy, methylenedioxy, nitro, azido, halogen, C₆ to C₁₀ aryl, C₆ to C₁₀ aryloxy, and aralkyloxy composed of a C₆ to C₁₀ aryl moiety and a C₁ to C₂ alkyl moiety, group β: adenine guanine, cytosine and thymine.
通式(1)代表的化合物、其盐以及含有该通式的抗病毒和抗肿瘤药物,其中 k 为 0 至 20;m 为 0 或 1;n 为 4 至 29;X 代表 OH、甲基、巯基、C₁ 至 C₄ 烷氧基或 C₁ 至 C₆ 单烷基氨基;Y 和 Z 各自代表 O 或 S;R¹、R²和R³可以相同或不同,各自代表H、C₁至C₆烷基或C₆至C₁₀芳基,可具有α基团的取代基;D和B各自独立地代表β基团的任何化合物的残基;条件是当k为0时,m为0,且含有B的碱基序列与肿瘤基因或病毒基因互补:第 α 组OH, C₁ to C₆ alkyl, C₁ to C₆ alkoxy, methylenedioxy, nitro, azido, halogen, C₆ to C₁₀ aryl, C₆ to C₁₀ aryloxy, and aralkyloxy composed of a C₆ to C₁₀ aryl moiety and a C₁ to C₂ alkyl moiety, group β:腺嘌呤、鸟嘌呤、胞嘧啶和胸腺嘧啶。